使用单个PET扫描对人类大脑药物占用率的评估:A[11C]UCB-J PET研究
Maja R Marstrand-Joergensen1,2,3,4, Gjertrud L Laurell2,5,6, Susan Herrmann7
1Epilepsy Clinic, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, Copenhagen O, 2100, Denmark.
概括
这项研究验证了一种PET位移模型,用于测量 levetiracetam (LEV) 对健康个体的突触囊泡糖蛋白2A (SV2A) 占用率. 该模型使用单个PET扫描精确确定LEV-SV2A结合,为未来治疗疗效研究铺平了道路.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 放射化学 放射化学是指辐射化学.
背景情况:
- 突触囊泡糖蛋白2A (SV2A) 是抗药物的标.
- 像[11C]UCB-J这样的正子发射断层扫描 (PET) 标记器允许可视化大脑中的SV2A结合.
- 了解药物度和目标占用率之间的关系对于优化治疗至关重要.
研究的目的:
- 验证一种PET排位模型,用于量化 levetiracetam (LEV) 与SV2A.的结合.
- 用移位模型将从单个PET扫描中得出的LEV-SV2A占用率与两个PET扫描和拉森图的结果进行比较.
- 在健康个体中确定血LEV度-SV2A占用曲线.
主要方法:
- 11名健康人接受了两次[11C]UCB-J PET扫描,静脉注射不同剂量的LEV.
- 采集了动脉血液样本,以确定动脉输入功能并测量血LEV度.
- 使用PET位移模型 (单步和数值解决方案) 和拉森图形方法计算SV2A占用率和目标参与度.
主要成果:
- 与拉森图表相比,PET位移模型在SV2A占用率和VND估计中没有显著差异.
- 位移模型的变化系数与拉森图形相似.
- 据估计,LEV的平均半最大抑制度 (IC50) 在各方法中从6.3到12.5μg/mL不等.
结论:
- 一个单一的PET扫描位移模型可以有效地确定人体血LEV度与SV2A占用率.
- 经过验证的模型提供了一种可靠的方法来评估抗发作药物的向参与.
- 未来的研究将利用这个模型来将LEV占用率与治疗疗效相关联.
更多相关视频
15:10A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat
Published on: December 28, 2013
7.0K
09:03Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
Published on: October 22, 2019
10.0K
相关概念视频
Positron Emission Tomography
4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
111
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
111
![PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F57243.jpg&w=3840&q=50)